The proposed bill, H. B. No. 2025-2026, aims to enhance transparency and access to prescription drugs for patients by enacting a new section, 3902.78, in the Revised Code of Ohio. This section prohibits health plan issuers, including pharmacy benefit managers and third-party administrators, from imposing restrictions or penalties on pharmacies, pharmacists, or prescribers who offer services or products that promote transparency and improve access to prescription medications.

The bill outlines specific services that cannot be restricted, including simplified payment processes, adherence support services, and the provision of information regarding out-of-pocket drug costs. Additionally, it allows for the use of electronic transactions to share information about prescription drug costs and benefits, provide prior authorization support, and share patient claims data with authorized parties. Furthermore, it permits the provision of copayment assistance or other support for out-of-pocket costs related to prescription drugs, as long as it complies with state and federal law.